Some studies report a positive relationship of APOE ε4 with more rapid cognitive decline in mild [46] and mild-to-moderate AD [47], while others report no significant influence on the rate of cognitive and functional progression [48,49], or that individuals with two ε4 alleles have a slower clinical course of AD [50]. Here, APOE is linked to Alzheimer disease.